Hyperosmolar Hyperglycemic State (HHS): Causes, Pathophysiology, Diagnosis, and Management
Long-term Management and Prevention: patient education, glycemic control strategies, addressing underlying causes
Hyperosmolar Hyperglycemic State (HHS) is a life-threatening condition in diabetes patients, requiring prompt diagnosis and management with IV fluids, electrolyte correction, and insulin therapy.
6/7/2025• 4 min read• 55 views
loved it
normalintermediatePathology
Hyperosmolar Hyperglycemic State (HHS): Causes, Pathophysiology, Diagnosis, and Management
Hyperosmolar Hyperglycemic State (HHS) is a severe complication of diabetes mellitus, characterized by extreme hyperglycemia, dehydration, and altered mental status.
Causes
- Poorly controlled diabetes
- Infection (e.g., pneumonia, urinary tract infection)
- Medications (e.g., corticosteroids, diuretics)
- Recent surgery or trauma
- Non-compliance with diabetes treatment
Pathophysiology
HHS is caused by insulin deficiency combined with a significant increase in counter-regulatory hormones, leading to marked hyperglycemia and osmotic diuresis.
Diagnosis
Laboratory findings in HHS include:
- Blood glucose > 600 mg/dL
- Serum osmolality > 320 mOsm/kg
- Severe dehydration and electrolyte imbalance
- Minimal to absent ketonemia
Management
Treatment includes aggressive IV fluid replacement, electrolyte correction, and insulin therapy.
Long-term Management and Prevention
- Patient education on diabetes management
- Regular monitoring of blood glucose levels
- Addressing underlying causes such as infections or medication issues
- Proper medication adherence and lifestyle modifications
Tags
#Hyperosmolar Hyperglycemic State#Diabetes Complications#Pathology#Medical Management
Recommended Reads
Explore related articles that might interest you
4
12%
Hyperosmolar Hyperglycemic State (HHS): Causes, Pathophysiology, Diagnosis, and Management
Read more →
4
17
12%
Hyperosmolar Hyperglycemic State (HHS): Causes, Pathophysiology, Diagnosis, and Management
Read more →
17
25
11%
Mediastinal Diseases
Read more →
25
16
11%
Classification and Staging of Cancer (AJCC, FIGO, TNM, etc.)
Read more →
16
2
11%
Crossmatching and Blood Component Transfusion Procedures
Read more →
2
28
11%
Radiotherapy for Benign Diseases
Read more →
28
12
11%
Immunological mechanisms in maintaining health
Read more →
12